TCL Archive “A significant reduction in the NCI IRP AIDS program may be in order, and released funds should … increase the pool available to extramural research.” July 21, 1995
TCL Archive DOD Bill Passes Senate; Prostate Cancer Gets $75 Mil.; Breast Cancer Recieves $175 Mil. June 25, 1999
TCL Archive Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations August 31, 2001
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
